Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global COVID-19 Rapid Antibody Test Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Global COVID-19 Rapid Antibody Test Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 155 Pages
Report ld: 5344193
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
COVID-19 Rapid Antibody Test Kits Market Size(US$)
CAGR 2025-2031
-21.7%
Market Size,2031
USD 2,327
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 10,100 million
Market Forecast in 2031(Value)
US$ 2,327 million
CAGR
-21.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global COVID-19 Rapid Antibody Test Kits market is projected to grow from US$ 12550 million in 2024 to US$ 2327 million by 2031, at a CAGR of -21.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
COVID-19 Rapid Antibody Test Kits leading manufacturers including RayBiotech Life, Aurora Biomed, SD Biosensor, Abingdon Health, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics, TestLine Clinical Diagnostics, etc., dominate supply; the top five capture approximately % of global revenue, with RayBiotech Life leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global COVID-19 Rapid Antibody Test Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- RayBiotech Life
- Aurora Biomed
- SD Biosensor
- Abingdon Health
- INSTI
- CTK Biotech
- SBL Testing Technologies
- Biopanda
- Roche Diagnostics
- TestLine Clinical Diagnostics
- Assay Genie
- Nadal-test
- Panodyne
- Luminex
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- IgG Test
- IgM Test
- Others
Segment by Application
- Hospital
- Company
- School
- Home
- Others
CHAPTER OUTLINE
Chapter 1: Defines the COVID-19 Rapid Antibody Test Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to COVID-19 Rapid Antibody Test Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global COVID-19 Rapid Antibody Test Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgG Test
1.2.3 IgM Test
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global COVID-19 Rapid Antibody Test Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Company
1.3.4 School
1.3.5 Home
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global COVID-19 Rapid Antibody Test Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global COVID-19 Rapid Antibody Test Kits Sales Estimates and Forecasts 2020-2031
2.4 Global COVID-19 Rapid Antibody Test Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global COVID-19 Rapid Antibody Test Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global COVID-19 Rapid Antibody Test Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 IgG Test Market Size by Manufacturers
3.5.2 IgM Test Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global COVID-19 Rapid Antibody Test Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global COVID-19 Rapid Antibody Test Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global COVID-19 Rapid Antibody Test Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global COVID-19 Rapid Antibody Test Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America COVID-19 Rapid Antibody Test Kits Sales and Revenue by Type (2020-2031)
6.4 North America COVID-19 Rapid Antibody Test Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America COVID-19 Rapid Antibody Test Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe COVID-19 Rapid Antibody Test Kits Sales and Revenue by Type (2020-2031)
7.4 Europe COVID-19 Rapid Antibody Test Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe COVID-19 Rapid Antibody Test Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific COVID-19 Rapid Antibody Test Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America COVID-19 Rapid Antibody Test Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America COVID-19 Rapid Antibody Test Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America COVID-19 Rapid Antibody Test Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa COVID-19 Rapid Antibody Test Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 RayBiotech Life
11.1.1 RayBiotech Life Corporation Information
11.1.2 RayBiotech Life Business Overview
11.1.3 RayBiotech Life COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.1.4 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales by Product in 2024
11.1.6 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales by Application in 2024
11.1.7 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales by Geographic Area in 2024
11.1.8 RayBiotech Life COVID-19 Rapid Antibody Test Kits SWOT Analysis
11.1.9 RayBiotech Life Recent Developments
11.2 Aurora Biomed
11.2.1 Aurora Biomed Corporation Information
11.2.2 Aurora Biomed Business Overview
11.2.3 Aurora Biomed COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.2.4 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales by Product in 2024
11.2.6 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales by Application in 2024
11.2.7 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales by Geographic Area in 2024
11.2.8 Aurora Biomed COVID-19 Rapid Antibody Test Kits SWOT Analysis
11.2.9 Aurora Biomed Recent Developments
11.3 SD Biosensor
11.3.1 SD Biosensor Corporation Information
11.3.2 SD Biosensor Business Overview
11.3.3 SD Biosensor COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.3.4 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales by Product in 2024
11.3.6 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales by Application in 2024
11.3.7 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales by Geographic Area in 2024
11.3.8 SD Biosensor COVID-19 Rapid Antibody Test Kits SWOT Analysis
11.3.9 SD Biosensor Recent Developments
11.4 Abingdon Health
11.4.1 Abingdon Health Corporation Information
11.4.2 Abingdon Health Business Overview
11.4.3 Abingdon Health COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.4.4 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales by Product in 2024
11.4.6 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales by Application in 2024
11.4.7 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales by Geographic Area in 2024
11.4.8 Abingdon Health COVID-19 Rapid Antibody Test Kits SWOT Analysis
11.4.9 Abingdon Health Recent Developments
11.5 INSTI
11.5.1 INSTI Corporation Information
11.5.2 INSTI Business Overview
11.5.3 INSTI COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.5.4 INSTI COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 INSTI COVID-19 Rapid Antibody Test Kits Sales by Product in 2024
11.5.6 INSTI COVID-19 Rapid Antibody Test Kits Sales by Application in 2024
11.5.7 INSTI COVID-19 Rapid Antibody Test Kits Sales by Geographic Area in 2024
11.5.8 INSTI COVID-19 Rapid Antibody Test Kits SWOT Analysis
11.5.9 INSTI Recent Developments
11.6 CTK Biotech
11.6.1 CTK Biotech Corporation Information
11.6.2 CTK Biotech Business Overview
11.6.3 CTK Biotech COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.6.4 CTK Biotech COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 CTK Biotech Recent Developments
11.7 SBL Testing Technologies
11.7.1 SBL Testing Technologies Corporation Information
11.7.2 SBL Testing Technologies Business Overview
11.7.3 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.7.4 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 SBL Testing Technologies Recent Developments
11.8 Biopanda
11.8.1 Biopanda Corporation Information
11.8.2 Biopanda Business Overview
11.8.3 Biopanda COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.8.4 Biopanda COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Biopanda Recent Developments
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Corporation Information
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.9.4 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Roche Diagnostics Recent Developments
11.10 TestLine Clinical Diagnostics
11.10.1 TestLine Clinical Diagnostics Corporation Information
11.10.2 TestLine Clinical Diagnostics Business Overview
11.10.3 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.10.4 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 TestLine Clinical Diagnostics Recent Developments
11.11 Assay Genie
11.11.1 Assay Genie Corporation Information
11.11.2 Assay Genie Business Overview
11.11.3 Assay Genie COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.11.4 Assay Genie COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Assay Genie Recent Developments
11.12 Nadal-test
11.12.1 Nadal-test Corporation Information
11.12.2 Nadal-test Business Overview
11.12.3 Nadal-test COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.12.4 Nadal-test COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Nadal-test Recent Developments
11.13 Panodyne
11.13.1 Panodyne Corporation Information
11.13.2 Panodyne Business Overview
11.13.3 Panodyne COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.13.4 Panodyne COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Panodyne Recent Developments
11.14 Luminex
11.14.1 Luminex Corporation Information
11.14.2 Luminex Business Overview
11.14.3 Luminex COVID-19 Rapid Antibody Test Kits Product Models, Descriptions and Specifications
11.14.4 Luminex COVID-19 Rapid Antibody Test Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Luminex Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 COVID-19 Rapid Antibody Test Kits Industry Chain
12.2 COVID-19 Rapid Antibody Test Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 COVID-19 Rapid Antibody Test Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 COVID-19 Rapid Antibody Test Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 COVID-19 Rapid Antibody Test Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global COVID-19 Rapid Antibody Test Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global COVID-19 Rapid Antibody Test Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global COVID-19 Rapid Antibody Test Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global COVID-19 Rapid Antibody Test Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global COVID-19 Rapid Antibody Test Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global COVID-19 Rapid Antibody Test Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global COVID-19 Rapid Antibody Test Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global COVID-19 Rapid Antibody Test Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global COVID-19 Rapid Antibody Test Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global COVID-19 Rapid Antibody Test Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global COVID-19 Rapid Antibody Test Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global COVID-19 Rapid Antibody Test Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Rapid Antibody Test Kits as of 2024)
Table 16. Global COVID-19 Rapid Antibody Test Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global COVID-19 Rapid Antibody Test Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers COVID-19 Rapid Antibody Test Kits Manufacturing Base and Headquarters
Table 19. Global COVID-19 Rapid Antibody Test Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global COVID-19 Rapid Antibody Test Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global COVID-19 Rapid Antibody Test Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global COVID-19 Rapid Antibody Test Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global COVID-19 Rapid Antibody Test Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global COVID-19 Rapid Antibody Test Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global COVID-19 Rapid Antibody Test Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global COVID-19 Rapid Antibody Test Kits Sales by Application (2026-2031) & (K Units)
Table 30. COVID-19 Rapid Antibody Test Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global COVID-19 Rapid Antibody Test Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global COVID-19 Rapid Antibody Test Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global COVID-19 Rapid Antibody Test Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America COVID-19 Rapid Antibody Test Kits Growth Accelerators and Market Barriers
Table 37. North America COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America COVID-19 Rapid Antibody Test Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe COVID-19 Rapid Antibody Test Kits Growth Accelerators and Market Barriers
Table 40. Europe COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe COVID-19 Rapid Antibody Test Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific COVID-19 Rapid Antibody Test Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America COVID-19 Rapid Antibody Test Kits Investment Opportunities and Key Challenges
Table 47. Central and South America COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa COVID-19 Rapid Antibody Test Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. RayBiotech Life Corporation Information
Table 51. RayBiotech Life Description and Major Businesses
Table 52. RayBiotech Life Product Models, Descriptions and Specifications
Table 53. RayBiotech Life Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. RayBiotech Life Sales Value Proportion by Product in 2024
Table 55. RayBiotech Life Sales Value Proportion by Application in 2024
Table 56. RayBiotech Life Sales Value Proportion by Geographic Area in 2024
Table 57. RayBiotech Life COVID-19 Rapid Antibody Test Kits SWOT Analysis
Table 58. RayBiotech Life Recent Developments
Table 59. Aurora Biomed Corporation Information
Table 60. Aurora Biomed Description and Major Businesses
Table 61. Aurora Biomed Product Models, Descriptions and Specifications
Table 62. Aurora Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Aurora Biomed Sales Value Proportion by Product in 2024
Table 64. Aurora Biomed Sales Value Proportion by Application in 2024
Table 65. Aurora Biomed Sales Value Proportion by Geographic Area in 2024
Table 66. Aurora Biomed COVID-19 Rapid Antibody Test Kits SWOT Analysis
Table 67. Aurora Biomed Recent Developments
Table 68. SD Biosensor Corporation Information
Table 69. SD Biosensor Description and Major Businesses
Table 70. SD Biosensor Product Models, Descriptions and Specifications
Table 71. SD Biosensor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. SD Biosensor Sales Value Proportion by Product in 2024
Table 73. SD Biosensor Sales Value Proportion by Application in 2024
Table 74. SD Biosensor Sales Value Proportion by Geographic Area in 2024
Table 75. SD Biosensor COVID-19 Rapid Antibody Test Kits SWOT Analysis
Table 76. SD Biosensor Recent Developments
Table 77. Abingdon Health Corporation Information
Table 78. Abingdon Health Description and Major Businesses
Table 79. Abingdon Health Product Models, Descriptions and Specifications
Table 80. Abingdon Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Abingdon Health Sales Value Proportion by Product in 2024
Table 82. Abingdon Health Sales Value Proportion by Application in 2024
Table 83. Abingdon Health Sales Value Proportion by Geographic Area in 2024
Table 84. Abingdon Health COVID-19 Rapid Antibody Test Kits SWOT Analysis
Table 85. Abingdon Health Recent Developments
Table 86. INSTI Corporation Information
Table 87. INSTI Description and Major Businesses
Table 88. INSTI Product Models, Descriptions and Specifications
Table 89. INSTI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. INSTI Sales Value Proportion by Product in 2024
Table 91. INSTI Sales Value Proportion by Application in 2024
Table 92. INSTI Sales Value Proportion by Geographic Area in 2024
Table 93. INSTI COVID-19 Rapid Antibody Test Kits SWOT Analysis
Table 94. INSTI Recent Developments
Table 95. CTK Biotech Corporation Information
Table 96. CTK Biotech Description and Major Businesses
Table 97. CTK Biotech Product Models, Descriptions and Specifications
Table 98. CTK Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. CTK Biotech Recent Developments
Table 100. SBL Testing Technologies Corporation Information
Table 101. SBL Testing Technologies Description and Major Businesses
Table 102. SBL Testing Technologies Product Models, Descriptions and Specifications
Table 103. SBL Testing Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. SBL Testing Technologies Recent Developments
Table 105. Biopanda Corporation Information
Table 106. Biopanda Description and Major Businesses
Table 107. Biopanda Product Models, Descriptions and Specifications
Table 108. Biopanda Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Biopanda Recent Developments
Table 110. Roche Diagnostics Corporation Information
Table 111. Roche Diagnostics Description and Major Businesses
Table 112. Roche Diagnostics Product Models, Descriptions and Specifications
Table 113. Roche Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Roche Diagnostics Recent Developments
Table 115. TestLine Clinical Diagnostics Corporation Information
Table 116. TestLine Clinical Diagnostics Description and Major Businesses
Table 117. TestLine Clinical Diagnostics Product Models, Descriptions and Specifications
Table 118. TestLine Clinical Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. TestLine Clinical Diagnostics Recent Developments
Table 120. Assay Genie Corporation Information
Table 121. Assay Genie Description and Major Businesses
Table 122. Assay Genie Product Models, Descriptions and Specifications
Table 123. Assay Genie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Assay Genie Recent Developments
Table 125. Nadal-test Corporation Information
Table 126. Nadal-test Description and Major Businesses
Table 127. Nadal-test Product Models, Descriptions and Specifications
Table 128. Nadal-test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Nadal-test Recent Developments
Table 130. Panodyne Corporation Information
Table 131. Panodyne Description and Major Businesses
Table 132. Panodyne Product Models, Descriptions and Specifications
Table 133. Panodyne Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Panodyne Recent Developments
Table 135. Luminex Corporation Information
Table 136. Luminex Description and Major Businesses
Table 137. Luminex Product Models, Descriptions and Specifications
Table 138. Luminex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Luminex Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. COVID-19 Rapid Antibody Test Kits Product Picture
Figure 2. Global COVID-19 Rapid Antibody Test Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. IgG Test Product Picture
Figure 4. IgM Test Product Picture
Figure 5. Others Product Picture
Figure 6. Global COVID-19 Rapid Antibody Test Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Company
Figure 9. School
Figure 10. Home
Figure 11. Others
Figure 12. COVID-19 Rapid Antibody Test Kits Report Years Considered
Figure 13. Global COVID-19 Rapid Antibody Test Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 15. Global COVID-19 Rapid Antibody Test Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Region (2020-2031)
Figure 17. Global COVID-19 Rapid Antibody Test Kits Sales (2020-2031) & (K Units)
Figure 18. Global COVID-19 Rapid Antibody Test Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Volume Market Share in 2024
Figure 21. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. IgG Test Revenue Market Share by Manufacturer in 2024
Figure 24. IgM Test Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Type (2020-2031)
Figure 27. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Type (2020-2031)
Figure 28. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Application (2020-2031)
Figure 29. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Application (2020-2031)
Figure 30. North America COVID-19 Rapid Antibody Test Kits Sales YoY (2020-2031) & (K Units)
Figure 31. North America COVID-19 Rapid Antibody Test Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) in 2024
Figure 33. North America COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 38. Canada COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 40. Europe COVID-19 Rapid Antibody Test Kits Sales YoY (2020-2031) & (K Units)
Figure 41. Europe COVID-19 Rapid Antibody Test Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) in 2024
Figure 43. Europe COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 48. France COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 50. Italy COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 51. Russia COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific COVID-19 Rapid Antibody Test Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 60. Japan COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 63. India COVID-19 Rapid Antibody Test Kits Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America COVID-19 Rapid Antibody Test Kits Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America COVID-19 Rapid Antibody Test Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa COVID-19 Rapid Antibody Test Kits Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa COVID-19 Rapid Antibody Test Kits Revenue (2020-2025) & (US$ Million)
Figure 84. COVID-19 Rapid Antibody Test Kits Industry Chain Mapping
Figure 85. Regional COVID-19 Rapid Antibody Test Kits Manufacturing Base Distribution (%)
Figure 86. Global COVID-19 Rapid Antibody Test Kits Production Market Share by Region (2020-2031)
Figure 87. COVID-19 Rapid Antibody Test Kits Production Process
Figure 88. Regional COVID-19 Rapid Antibody Test Kits Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global COVID-19 Rapid Antibody Test Kits market?
The top companies in the global COVID-19 Rapid Antibody Test Kits market are RayBiotech Life、Aurora Biomed、SD Biosensor.
Which region is expected to have the highest market share?
What was the global market size of COVID-19 Rapid Antibody Test Kits in 2025?
What is the annual compound growth rate of the global COVID-19 Rapid Antibody Test Kits market size from 2025 to 2031?
What was the global market size of COVID-19 Rapid Antibody Test Kits in 2031?
Related Reports
COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2026
The global COVID-19 Rapid Antibody Test Kits market was valued at US$ 10100 million in 2025 and is anticipated to reach US$ 1873 million by 2032, at a CAGR of -21.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 127
USD 3950.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2025
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2024
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)Global COVID-19 Rapid Antibody Test Kits Market Research Report 2026
The global COVID-19 Rapid Antibody Test Kits market was valued at US$ 10100 million in 2025 and is anticipated to reach US$ 1873 million by 2032, at a CAGR of -21.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
USD 2900.00 (Single User License)Global COVID-19 Rapid Antibody Test Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
USD 4250.00 (Single User License)COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 127
USD 3950.00 (Single User License)Global COVID-19 Rapid Antibody Test Kits Market Research Report 2025
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)Global COVID-19 Rapid Antibody Test Kits Market Research Report 2024
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now